Ibuprofen Inn-Farm

Ibuprofen, the active ingredient in Ibuprofen Inn-Farm, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It treats pain, fever, inflammation and arthritis in adults and children as directed by a healthcare professional, and is marketed in the European Union.

GNH USA supplies Ibuprofen Inn-Farm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable bulk sourcing for diverse healthcare settings.

Ibuprofen acts on inflammatory pathways to relieve symptoms across several common conditions.

Pain: Reduces mild to moderate nociceptive pain. Fever: Lowers elevated body temperature. Inflammation: Decreases swelling and redness associated with acute inflammatory processes. Arthritis: Alleviates joint pain and stiffness in osteoarthritis and rheumatoid arthritis.

Ibuprofen may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal upset, such as nausea or dyspepsia. - Headache or dizziness. - Mild skin rash. - Transient elevation of liver enzymes.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Acute renal impairment or failure. - Severe hypersensitivity reactions, including anaphylaxis. - Hepatotoxicity or severe liver injury.

Before using Ibuprofen Inn-Farm, consider the following precautions to minimize risk.

Assess renal function: Adjust use in patients with existing kidney disease. Monitor gastrointestinal health: Avoid in individuals with active ulcer disease or recent GI bleeding. Use lowest effective dose: Limit duration to reduce risk of adverse events. Avoid in third‑trimester pregnancy: Consult a healthcare professional before use. Store at ambient temperature: Keep in the original container, protect from moisture and heat.

Ibuprofen can interact with other medicines, altering their effects or increasing adverse events.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): Increased risk of serious bleeding. - Selective serotonin reuptake inhibitors (SSRIs): Heightened potential for gastrointestinal hemorrhage.

Moderate Interactions (Monitor Closely): - ACE inhibitors: May reduce renal function, especially in volume‑depleted patients. - Diuretics: Potential for electrolyte imbalance and reduced antihypertensive effect. - Lithium: Ibuprofen can raise lithium serum concentrations, requiring close monitoring.